- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x AR6: [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL [HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE(Non-covalent)
- 6 x ZN: ZINC ION(Non-covalent)
ZN.2: 4 residues within 4Å:- Chain A: C.135, C.138, C.160, C.171
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.135, A:C.138, A:C.160, A:C.171
ZN.10: 4 residues within 4Å:- Chain B: C.135, C.138, C.160, C.171
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.135, B:C.138, B:C.160, B:C.171
ZN.14: 4 residues within 4Å:- Chain C: C.135, C.138, C.160, C.171
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:C.135, C:C.138, C:C.160, C:C.171
ZN.22: 4 residues within 4Å:- Chain D: C.135, C.138, C.160, C.171
4 PLIP interactions:4 interactions with chain D- Metal complexes: D:C.135, D:C.138, D:C.160, D:C.171
ZN.26: 4 residues within 4Å:- Chain E: C.135, C.138, C.160, C.171
4 PLIP interactions:4 interactions with chain E- Metal complexes: E:C.135, E:C.138, E:C.160, E:C.171
ZN.34: 4 residues within 4Å:- Chain F: C.135, C.138, C.160, C.171
4 PLIP interactions:4 interactions with chain F- Metal complexes: F:C.135, F:C.138, F:C.160, F:C.171
- 3 x 01: 2,4-bis(oxidanylidene)-1-[2-oxidanylidene-2-[[(2S)-3-oxidanylidene-3-(propylamino)-2-[3-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)propanoylamino]propyl]amino]ethyl]pyrimidine-5-carboxamide
01.3: 15 residues within 4Å:- Chain A: I.55, P.56, F.58, F.76, T.78, T.79, F.80, V.109, H.127, M.130, M.151, I.179, L.180, W.182
- Ligands: AR6.1
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:F.58, A:F.58, A:V.109, A:I.179, A:L.180
- Hydrogen bonds: A:T.78, A:L.180
- pi-Stacking: A:F.80, A:W.182
01.15: 15 residues within 4Å:- Chain C: I.55, P.56, F.58, F.76, T.78, T.79, F.80, V.109, H.127, M.130, M.151, I.179, L.180, W.182
- Ligands: AR6.13
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:F.58, C:F.58, C:V.109, C:I.179, C:L.180
- Hydrogen bonds: C:T.78, C:L.180
- pi-Stacking: C:F.80, C:W.182
01.27: 15 residues within 4Å:- Chain E: I.55, P.56, F.58, F.76, T.78, T.79, F.80, V.109, H.127, M.130, M.151, I.179, L.180, W.182
- Ligands: AR6.25
9 PLIP interactions:9 interactions with chain E- Hydrophobic interactions: E:F.58, E:F.58, E:V.109, E:I.179, E:L.180
- Hydrogen bonds: E:T.78, E:L.180
- pi-Stacking: E:F.80, E:W.182
- 21 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 5 residues within 4Å:- Chain A: H.62, K.75, D.77
- Chain B: H.62, K.75
Ligand excluded by PLIPSO4.5: 6 residues within 4Å:- Chain A: R.84, A.269, W.270
- Chain B: R.84, A.269, W.270
Ligand excluded by PLIPSO4.6: 3 residues within 4Å:- Chain A: K.27, R.247, H.249
Ligand excluded by PLIPSO4.7: 2 residues within 4Å:- Chain A: P.215, N.218
Ligand excluded by PLIPSO4.8: 3 residues within 4Å:- Chain A: G.152, L.153, R.176
Ligand excluded by PLIPSO4.11: 3 residues within 4Å:- Chain B: K.27, R.247, H.249
Ligand excluded by PLIPSO4.12: 3 residues within 4Å:- Chain B: R.214, P.215, N.218
Ligand excluded by PLIPSO4.16: 5 residues within 4Å:- Chain C: H.62, K.75, D.77
- Chain D: H.62, K.75
Ligand excluded by PLIPSO4.17: 6 residues within 4Å:- Chain C: R.84, A.269, W.270
- Chain D: R.84, A.269, W.270
Ligand excluded by PLIPSO4.18: 3 residues within 4Å:- Chain C: K.27, R.247, H.249
Ligand excluded by PLIPSO4.19: 2 residues within 4Å:- Chain C: P.215, N.218
Ligand excluded by PLIPSO4.20: 3 residues within 4Å:- Chain C: G.152, L.153, R.176
Ligand excluded by PLIPSO4.23: 3 residues within 4Å:- Chain D: K.27, R.247, H.249
Ligand excluded by PLIPSO4.24: 3 residues within 4Å:- Chain D: R.214, P.215, N.218
Ligand excluded by PLIPSO4.28: 5 residues within 4Å:- Chain E: H.62, K.75, D.77
- Chain F: H.62, K.75
Ligand excluded by PLIPSO4.29: 6 residues within 4Å:- Chain E: R.84, A.269, W.270
- Chain F: R.84, A.269, W.270
Ligand excluded by PLIPSO4.30: 3 residues within 4Å:- Chain E: K.27, R.247, H.249
Ligand excluded by PLIPSO4.31: 2 residues within 4Å:- Chain E: P.215, N.218
Ligand excluded by PLIPSO4.32: 3 residues within 4Å:- Chain E: G.152, L.153, R.176
Ligand excluded by PLIPSO4.35: 3 residues within 4Å:- Chain F: K.27, R.247, H.249
Ligand excluded by PLIPSO4.36: 3 residues within 4Å:- Chain F: R.214, P.215, N.218
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- You, W. et al., Elucidating the Unconventional Binding Mode of a DNA-Encoded Library Hit Provides a Blueprint for Sirtuin 6 Inhibitor Development. Chemmedchem (2024)
- Release Date
- 2024-08-14
- Peptides
- NAD-dependent protein deacetylase sirtuin-6: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x AR6: [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL [HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE(Non-covalent)
- 6 x ZN: ZINC ION(Non-covalent)
- 3 x 01: 2,4-bis(oxidanylidene)-1-[2-oxidanylidene-2-[[(2S)-3-oxidanylidene-3-(propylamino)-2-[3-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)propanoylamino]propyl]amino]ethyl]pyrimidine-5-carboxamide
- 21 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- You, W. et al., Elucidating the Unconventional Binding Mode of a DNA-Encoded Library Hit Provides a Blueprint for Sirtuin 6 Inhibitor Development. Chemmedchem (2024)
- Release Date
- 2024-08-14
- Peptides
- NAD-dependent protein deacetylase sirtuin-6: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B